Stop TB’s Global Drug Facility Announces 38% Price Decrease for BPaLMRegimen and Newly-Available Drug-Sensitivity Tests

6 days ago1 min read

Updated: 5 days ago

The Stop TB Partnership announced a major price reduction on bedaquiline. The cost per

treatment course was slashed by over 50%, resulting in a new cost of 90 USD. This

decrease brings the BPaLM regimen down to 364 USD per treatment course. This price

reduction will make treatment more accessible. Read more here.

Recent Posts

A recent study on the incidence of MDR-TB in children and teens revealed that the prevalence has resurged. there was a 10 year drop from...

The shutdown and dismantling of USAID has had large ramifications for TB services. As one of the largest funding sources for TB, the...

A new study revealed that resistance is developing to the 6-month BPaLM regimen recommended by the WHO. The study investigated around...